+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of the novel anti-convulsant vigabatrin on functional recovery following brain lesion



Impact of the novel anti-convulsant vigabatrin on functional recovery following brain lesion



Restorative Neurology and Neuroscience 14(1): 35-45



GABAergic drugs can positively or negatively influence recovery of neurobehavioral function following brain injury. Direct potentiation of GABA-mediated inhibition at the post-synaptic receptor (i.e., via GABA, muscimol, diazepam, phenobarbital) after brain damage has been associated with impaired functional recovery. What remains unclear, however, is whether the mechanism of action by which GABA is augmented contributes to a drug's impact on the recovery process. Vigabatrin, a novel anti-convulsant that inhibits GABA-transaminase, was administered chronically after unilateral anteromedial cortex lesions and recovery from somatosensory deficits assessed. In contrast to the direct GABA receptor agonists, vigabatrin did not adversely impact (i.e., was neutral) recovery from neurobehavioral deficits at any of the anti-convulsant doses tested. Measurable secondary drug effects like sedation and hypothermia diminished over time and were reversible upon drug discontinuation. These results suggest that the degree to which a GABAergic agent impacts the recovery process after brain injury is dependent on the drug's mechanism of action.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 049298069

Download citation: RISBibTeXText

PMID: 12671269


Related references

Vigabatrin--a new anti-convulsant. Drug and Therapeutics Bulletin 28(24): 95-96, 1990

Vigabatrin coupled with kindling after brain damage Impact on behavioral recovery. Society for Neuroscience Abstracts 23(1-2): 228, 1997

Effects of convulsant and anti convulsant drugs on amino acid level of rat brain. Journal de Pharmacologie 4(2): 209-222, 1973

Biochemistry of central nervous system part 1 action of convulsant and anti convulsant drugs on brain pyridoxal enzymes. Therapie (London/Paris) 27(4): 667-679, 1972

Effects of convulsant and anti convulsant drugs on the uptake of carbon 14 gamma amino butyric acid by rat brain slices. Journal De Pharmacologie (paris): 295-306, 1973

Effect of convulsant and anti convulsant drugs on putative amino acid neuro transmitter content in rat brain regions. Neuroscience Letters Suppl.(3): S337, 1979

Effects of convulsant and anti convulsant drugs on the spontaneous and induced release of gamma amino butyric acid carbon 14 from cortex slices of rat brain. Journal de Pharmacologie 4(4): 433-452, 1973

Functional recovery after brain lesion--contralateral neuromodulation: an fMRI study. Neuroreport 12(7): 1543-1547, 2001

Amygdala kindling prior to brain lesion Impact on recovery from behavioral deficits. Epilepsia 36(Suppl. 4): 121, 1995

Associations between gait patterns, brain lesion factors and functional recovery in stroke patients. Gait and Posture 35(2): 214-217, 2012

Functional recovery in macaque monkeys subjected to unilateral spinal lesion effect of anti - Nogo treatment. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 275 9, 2003

Propentofylline after focal cortical lesion in the rat: Impact on functional recovery and basic fibroblast growth factor expression. Neuroscience Letters 331(3): 188-192, 2002

Propentofylline after focal cortical lesion Impact on functional recovery and basic fibroblast growth factor expression. Society for Neuroscience Abstracts 25(1-2): 1064, 1999

Brain lesion size and location: effects on motor recovery and functional outcome in stroke patients. Archives of Physical Medicine and Rehabilitation 81(4): 447-452, 2000

Anti convulsant activity of dextro 5 methyl 10 11 di hydro 5h di benzo a d cyclohepten 5 10 imine mk 801 a substance with potent anti convulsant central sympathomimetic and apparent anxiolytic properties. Drug Development Research 2(2): 123-134, 1982